| Dr Daniel Adam Sleve, MD | |
|
4880 Ne Goodview Circle, Lees Summit, MO 64064 | |
| (816) 478-4200 | |
| (816) 478-0507 |
| Full Name | Dr Daniel Adam Sleve |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 11 Years |
| Location | 4880 Ne Goodview Circle, Lees Summit, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1487812707 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 2013021876 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ray County Memorial Hospital | Richmond, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ascentist Physicians Group Llc | 9335143759 | 107 |
| Ascentist Physicians Group Llc | 9335143759 | 107 |
News Archive
Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on'), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.
› Verified 4 days ago
| Entity Name | Ray County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245220052 PECOS PAC ID: 4688560634 Enrollment ID: O20040225001164 |
News Archive
Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on'), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.
› Verified 4 days ago
| Entity Name | Ascentist Physicians Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060826000062 |
News Archive
Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on'), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.
› Verified 4 days ago
| Entity Name | Western Missouri Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386832277 PECOS PAC ID: 2668554932 Enrollment ID: O20080124000631 |
News Archive
Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on'), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Adam Sleve, MD 3340 Ne Ralph Powell Road, Suite B, Lees Summit, MO 64064 Ph: (816) 875-2599 | Dr Daniel Adam Sleve, MD 4880 Ne Goodview Circle, Lees Summit, MO 64064 Ph: (816) 478-4200 |
News Archive
Doctors in Germany have determined that patients suffering from early-stage Hodgkin's lymphoma can receive a reduced dose of involved field radiation therapy, combined with chemotherapy, and still retain a high survival rate, according to a study presented October 17, 2005, at the American Society for Therapeutic Radiology and Oncology's 47th Annual Meeting in Denver.
Repligen Corporation today reported results for the second quarter of fiscal year 2010, ended September 30, 2009. Total revenue for the quarter was $5,421,000 compared to total revenue of $5,090,000 for the second quarter of fiscal year 2009 ended September 30, 2008.
The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey.
American Biotech Labs, LLC, is pleased to announce the availability of three new silver hydrogel wound-dressing products.
New research shows that the quality of patient-physician communication, at the moment when additional oral type 2 diabetes (T2D) medication is prescribed (‘add-on'), is linked to future patient self-care and well-being.1 Data from the IntroDia™ Survey have quantitatively demonstrated this link in the largest international survey of its kind, using responses from 4,235 people with T2D across 26 countries.
› Verified 4 days ago
Dr. Andrew Sinclair Pavlovich, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 4880 Nw Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Dr. Colleen Nicole Johnson, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Cir, Ste 340, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 | |
Peter Andre Gochee, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Cir, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-875-2597 | |
Dr. Luke Jacob Dlabal Jr., MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 3601 Ne Ralph Powell Rd, Suite C, Lees Summit, MO 64064 Phone: 816-347-1514 Fax: 816-347-1822 | |
Dr. Mark Owen Covington, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Ne Goodview Cir, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-2597 | |
Dr. Kelvin L Walls, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4880 Nw Goodview Circle, Lees Summit, MO 64064 Phone: 816-478-4200 Fax: 816-478-0507 |